Hansa Biopharma AB ( HNSBF) - Key Metrics
HNSBF Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | ? | ? | ? | ? |
| 2026Q1 | ? | ? | ? | ? |
| 2025Q4 | $0.75 | -$1.62 | -$1.74 | -$1.74 |
| 2025Q3 | $0.36 | -$1.75 | -$1.06 | -$1.06 |
| 2025Q2 | $0.69 | -$2.53 | -$1.58 | -$1.58 |
HNSBF Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | ? | ? |
| 2026Q1 | ? | ? |
| 2025Q4 | ? | -5.30 |
| 2025Q3 | ? | -5.64 |
| 2025Q2 | ? | -2.59 |
HNSBF
Price: $3.70
52 week price:
Earnings Per Share: -0.78 USD
Exchange: PNK
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 369.0 million